SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from KIWA BIO-TECH PRODUCTS GROUP CORP (CIK 0001159275) — Dec 9, 2004

KIWA BIO-TECH PRODUCTS GROUP CORP (CIK 0001159275)
Date: Dec. 9, 2004 · CIK: 0001159275 · Accession: 0001170918-04-000731

AI Filing Summary & Sentiment

File numbers found in text: 333-117868

Date
December 9, 2004
Author
/s/ V. Joseph Stubbs
Form
CORRESP
Company
KIWA BIO-TECH PRODUCTS GROUP CORP (CIK 0001159275)

Letter

RE: KIWA BIO-TECH PRODUCTS GROUP CORPORATION RESPONSES TO STAFF COMMENTS OF DECEMBER 7, 2004 WITH RESPECT TO: AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM SB-2 FILE NO. 333-117868, FILED NOVEMBER 23, 2004

[STUBBS ALDERTON & MARKILES LLP LETTERHEAD]

JOSEPH STUBBS Partner Direct Voice 818.444.4507 Direct Fax 818.474.8607 Mobile 626.926.6018 E-Mail jstubbs@biztechlaw.com

December 9, 2004

Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549-1004

Ladies and Gentlemen:

On behalf of Kiwa Bio-Tech Products Group Corporation (the "COMPANY"), we hereby provide supplementally the following responses in reply to the Staff's comment letter, dated December 7, 2004 (the "COMMENT LETTER"). The factual information provided herein relating to the Company has been made available to us by the Company. Paragraph numbering used for each supplemental response set forth below corresponds to the numbering used in the Comment Letter.

FORM SB-2

EMPLOYMENT AGREEMENTS, PAGE 49

1. WE NOTE YOUR RESPONSE TO COMMENT 28 AND REISSUE THE COMMENT IN PART. PLEASE DESCRIBE ANY RESTRICTIVE COVENANTS AND OBLIGATIONS UNDER EACH OF THE AGREEMENTS YOU DESCRIBE IN THIS SECTION.

In response to the Staff prior comments, the Company included descriptions of the material terms and employment agreements between the Company and each of Lian-jun Luo and Qu Bin in the Executive Compensation section of Amendment No. 2 to the SB-2 Registration Statement. In addition, the Company filed copies of the employment agreements as Exhibit 10.13 and Exhibit 10.14 to Amendment No. 2 to the SB-2.

The Company believes that all material terms and obligations of the Company under the employment agreements have been disclosed in Amendment No. 2. The

15821 Ventura Boulevard, Suite 525, Encino, California 91436 office > 818.444.4500 fax > 818.444.4520 www.biztechlaw.com

<PAGE>

Securities and Exchange Commission December 9, 2004 Page 2

included disclosures describe the term of the agreements, compensation and severance payment obligations. There are no other material covenants or obligations of the Company under either of these employment agreements.

We supplementally note that each of the employment agreements do contain covenants of the employee which are standard and customary for employment agreements. These covenants include a covenant on behalf of the employee not to compete with the Company or solicit the Company's employees during the term of employment and covenants of confidentiality and nondisclosure of Company proprietary information. The Company respectfully asserts that no further disclosure in the SB-2 Registration Statement is necessary with respect to the employment agreements at this time. However, the Company will include disclosure of these employee covenants contained in the employment agreement in the next Prospectus Supplement or Post-Effect Amendment to the SB-2 Registration Statement.

We hope the above has been responsive to the Staff's comments. If you have any questions or require any additional information or documents, please telephone me at (818) 444-4507.

Sincerely,
/s/ V. Joseph Stubbs
---------------------------
V. Joseph Stubbs

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

[STUBBS ALDERTON & MARKILES LLP LETTERHEAD]

                                             JOSEPH STUBBS
                                             Partner
                                             Direct
                                             Voice        818.444.4507
                                             Direct Fax   818.474.8607
                                             Mobile       626.926.6018
                                             E-Mail       jstubbs@biztechlaw.com

December 9, 2004

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549-1004

         RE:      KIWA BIO-TECH PRODUCTS GROUP CORPORATION
                  RESPONSES TO STAFF COMMENTS OF DECEMBER 7, 2004
                  WITH RESPECT TO:
                  AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM SB-2
                  FILE NO. 333-117868, FILED NOVEMBER 23, 2004

Ladies and Gentlemen:

         On behalf of Kiwa Bio-Tech  Products Group Corporation (the "COMPANY"),
we hereby provide supplementally the following responses in reply to the Staff's
comment  letter,  dated  December 7, 2004 (the  "COMMENT  LETTER").  The factual
information  provided  herein relating to the Company has been made available to
us by the Company.  Paragraph numbering used for each supplemental  response set
forth below corresponds to the numbering used in the Comment Letter.

FORM SB-2

EMPLOYMENT AGREEMENTS, PAGE 49

         1.       WE NOTE YOUR RESPONSE TO COMMENT 28 AND REISSUE THE COMMENT IN
PART.  PLEASE DESCRIBE ANY RESTRICTIVE  COVENANTS AND OBLIGATIONS  UNDER EACH OF
THE AGREEMENTS YOU DESCRIBE IN THIS SECTION.

         In  response  to  the  Staff  prior  comments,   the  Company  included
descriptions of the material terms and employment agreements between the Company
and each of Lian-jun  Luo and Qu Bin in the  Executive  Compensation  section of
Amendment No. 2 to the SB-2  Registration  Statement.  In addition,  the Company
filed copies of the employment  agreements as Exhibit 10.13 and Exhibit 10.14 to
Amendment No. 2 to the SB-2.

         The Company  believes that all material  terms and  obligations  of the
Company under the employment  agreements have been disclosed in Amendment No. 2.
The

          15821 Ventura Boulevard, Suite 525, Encino, California 91436
           office > 818.444.4500 fax > 818.444.4520 www.biztechlaw.com

<PAGE>

Securities and Exchange Commission
December 9, 2004
Page 2

included  disclosures  describe  the term of the  agreements,  compensation  and
severance  payment  obligations.  There  are  no  other  material  covenants  or
obligations of the Company under either of these employment agreements.

         We  supplementally  note  that  each of the  employment  agreements  do
contain  covenants  of  the  employee  which  are  standard  and  customary  for
employment  agreements.  These  covenants  include a  covenant  on behalf of the
employee  not to compete  with the  Company or solicit the  Company's  employees
during the term of employment and covenants of confidentiality and nondisclosure
of Company proprietary  information.  The Company  respectfully  asserts that no
further disclosure in the SB-2 Registration  Statement is necessary with respect
to the  employment  agreements at this time.  However,  the Company will include
disclosure of these employee covenants contained in the employment  agreement in
the next Prospectus Supplement or Post-Effect Amendment to the SB-2 Registration
Statement.

         We hope the above has been responsive to the Staff's  comments.  If you
have any questions or require any additional  information  or documents,  please
telephone me at (818) 444-4507.

                                                     Sincerely,

                                                     /s/ V. Joseph Stubbs
                                                     ---------------------------
                                                     V. Joseph Stubbs

Enclosures
cc:      James Zhan

</TEXT>
</DOCUMENT>